Severe gram positive bacterial infection in an ulcerative colitis patient treated with Infliximab
2009; Oxford University Press; Volume: 4; Issue: 1 Linguagem: Inglês
10.1016/j.crohns.2009.08.005
ISSN1876-4479
AutoresMargarida Marques, Susana Rodrigues, Eva Mariz, José Pinto, Taciana Videira, Juan P. Brito, C. Reis, F. Simões-Ventura, Fernando Magro,
Tópico(s)Mycobacterium research and diagnosis
ResumoTumour necrosis factor-alpha (TNF-α) inhibitors represent an important treatment advance for a number of inflammatory conditions, including inflammatory bowel disease. Since their introduction in 1999, it has become clear that some biological therapies may be associated with an increased risk for bacterial infections. Herein we present the first case of septic arthritis and spine empyema, caused by S. aureus, in a 63 year-old patient with ulcerative colitis, who was under treatment with Infliximab and with 40mg per day of prednisolone.
Referência(s)